< Back to previous page
Researcher
Toon Van Gorp
- Disciplines:Cancer diagnosis, Cancer therapy, Oncological surgery, Cancer biology
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Oct 2019 → 30 Sep 2022
Projects
1 - 5 of 5
- Liquid biopsy and HRD testing in ovarian cancerFrom4 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PPP2R1A as a new biomarker in type-II endometrial cancers.From1 Jan 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Predictive genetic markers for targeted therapy in gynaecological cancers: bridging the gap between “one-size-fits-all” and personalized treatmentFrom8 Oct 2020 → 30 Sep 2022Funding: BOF - projects
- Predictive genetic markers in gynaecological cancers: how to improve targeted therapy.From1 Oct 2020 → TodayFunding: FWO fundamental clinical research fellowship
- Predictive genetic markers for targeted therapy in gynaecological malignancies: bridging the gap between “one-size-fits-all” and more personalised treatment approach.From1 Aug 2019 → 11 Oct 2023Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 140
- Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer(2024)
Authors: Ignace Vergote, Toon Van Gorp
- Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery(2024)
Authors: Jolien Ceusters, Wouter Froyman, Toon Van Gorp, Ruben Heremans, Thaïs Baert, Roxanne Wouters, Anne-Sophie Van Rompuy, An Coosemans, Dirk Timmerman, Ben Van Calster
- A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial(2024)
Authors: Tine Ottenbourgs, Toon Van Gorp, Thaïs Baert, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
- Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.(2024)
Authors: Toon Van Gorp, Ignace Vergote
Pages: 277 - 284 - Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients(2024)
Authors: Toon Van Gorp
- Association of Four Interleukin-8 Polymorphisms (-251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related Subtypes(2024)
Authors: Toon Van Gorp
- A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting.(2024)
Authors: Ann Vankerckhoven, Thaïs Baert, Toon Van Gorp, An Coosemans, Liesbet Lagae
- Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer(2023)
Authors: Toon Van Gorp, Ignace Vergote
Pages: 5400 - + - Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer(2023)
Authors: Toon Van Gorp
Pages: 2162 - 2174 - Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study(2023)
Authors: Toon Van Gorp